Release Date: 10/05/21 14:15 Summary: Appendix 3X - Initial Director's Interest Notice - L. Buck Price Sensitive: No Download Document 214.27KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status